Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Harry Penner Jr currently holds 16,500 shares of Celldex Therapeutics, Inc. (CLDX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Harry Penner Jr has been a net seller of CLDX stock. They have purchased $10.5K and sold $434.3K worth of shares.
Harry Penner Jr's most recent insider trade was on Jun 13, 2024, when they sold 16,500 shares at $0.00 per share.
Harry Penner Jr serves as Executive at Celldex Therapeutics, Inc. (CLDX). They have executed 13 insider transactions totaling $444.8K over their tenure at the company.
Harry Penner Jr holds the position of Executive at Celldex Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 17 years and currently hold a stake valued at $0.
Harry Penner Jr has shown a selling trading pattern, with $10.5K in total purchases and $434.3K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Harry Penner Jr was on Dec 6, 2013, when they sold $434.3K worth of CLDX shares. This transaction involved 17,728 shares at $24.50 per share.
Harry Penner Jr currently owns 16,500 shares of Celldex Therapeutics, Inc. (CLDX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Harry Penner Jr's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Harry Penner Jr has 13 Form 4 filings on record as an insider at Celldex Therapeutics, Inc..
Set alerts for Harry Penner Jr and 40,000+ other insiders.